HMPL-A251
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HMPL-A251, covering 2025-12-29 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors [Phase 1, Phase 2]